|Application of neurite orientation dispersion and density imaging (NODDI) to a tau pathology model of Alzheimer's disease|
N Colgan, B Siow, JM O'Callaghan, IF Harrison, JA Wells, HE Holmes, ...
Neuroimage 125, 739-744, 2016
|Microstructural characterization of normal and malignant human prostate tissue with vascular, extracellular, and restricted diffusion for cytometry in tumours magnetic …|
E Panagiotaki, RW Chan, N Dikaios, HU Ahmed, J O’Callaghan, ...
Investigative radiology 50 (4), 218-227, 2015
|In vivo imaging of tau pathology using multi-parametric quantitative MRI|
JA Wells, JM O'Callaghan, HE Holmes, NM Powell, RA Johnson, B Siow, ...
Neuroimage 111, 369-378, 2015
|Tissue magnetic susceptibility mapping as a marker of tau pathology in Alzheimer's disease|
J O'callaghan, H Holmes, N Powell, JA Wells, O Ismail, IF Harrison, ...
Neuroimage 159, 334-345, 2017
|Imaging the accumulation and suppression of tau pathology using multiparametric MRI|
HE Holmes, N Colgan, O Ismail, D Ma, NM Powell, JM O'Callaghan, ...
Neurobiology of aging 39, 184-194, 2016
|Is your system calibrated? MRI gradient system calibration for pre-clinical, high-resolution imaging|
J O’Callaghan, J Wells, S Richardson, H Holmes, Y Yu, S Walker-Samuel, ...
PLoS One 9 (5), e96568, 2014
|Comparison of in vivo and ex vivo MRI for the detection of structural abnormalities in a mouse model of tauopathy|
HE Holmes, NM Powell, D Ma, O Ismail, IF Harrison, JA Wells, N Colgan, ...
Frontiers in neuroinformatics 11, 20, 2017
|First-in-human in vivo non-invasive assessment of intra-tumoral metabolic heterogeneity in renal cell carcinoma|
M Tran, A Latifoltojar, JB Neves, MV Papoutsaki, F Gong, A Comment, ...
BJR| case reports 5 (3), 20190003, 2019
|Increased cerebral vascular reactivity in the tau expressing rTg4510 mouse: evidence against the role of tau pathology to impair vascular health in Alzheimer's disease|
JA Wells, HE Holmes, JM O'callaghan, N Colgan, O Ismail, EMC Fisher, ...
Journal of Cerebral Blood Flow & Metabolism 35 (3), 359-362, 2015
|VERDICT MRI for prostate cancer: intracellular volume fraction versus apparent diffusion coefficient|
EW Johnston, E Bonet-Carne, U Ferizi, B Yvernault, H Pye, D Patel, ...
Radiology 291 (2), 391-397, 2019
|Study the longitudinal in vivo and cross-sectional ex vivo brain volume difference for disease progression and treatment effect on mouse model of tauopathy using automated MRI …|
D Ma, HE Holmes, MJ Cardoso, M Modat, IF Harrison, NM Powell, ...
Frontiers in neuroscience 13, 11, 2019
|Fully-automated μMRI morphometric phenotyping of the Tc1 mouse model of Down syndrome|
NM Powell, M Modat, MJ Cardoso, D Ma, HE Holmes, Y Yu, ...
PLoS One 11 (9), e0162974, 2016
|Optic nerve thinning and neurosensory retinal degeneration in the rTg4510 mouse model of frontotemporal dementia|
IF Harrison, R Whitaker, PM Bertelli, JM O’Callaghan, L Csincsik, ...
Acta neuropathologica communications 7 (1), 1-14, 2019
|In vivo imaging of tau pathology using magnetic resonance imaging textural analysis|
N Colgan, B Ganeshan, IF Harrison, O Ismail, HE Holmes, JA Wells, ...
Frontiers in neuroscience 11, 599, 2017
|Hyperpolarised 13C MRI: a new horizon for non-invasive diagnosis of aggressive breast cancer|
O Abeyakoon, A Latifoltojar, F Gong, MV Papoutsaki, R Chowdhury, ...
BJR| case reports 5 (3), 20190026, 2019
|Noninvasive quantification of oxygen saturation in the portal and hepatic veins in healthy mice and those with colorectal liver metastases using QSM MRI|
E Finnerty, R Ramasawmy, J O’Callaghan, JJ Connell, M Lythgoe, ...
Magnetic resonance in medicine 81 (4), 2666-2675, 2019
|Glymphatic clearance impaired in a mouse model of tauopathy: captured using contrast-enhanced MRI|
IF Harrison, A Machhada, N Colgan, O Ismail, JM O'Callaghan, ...
Alzheimers Dement 11, P107, 2015
|P1‐029: Imaging the efficacy of microtubule stabilizing agent epothilone d in the rtg4510 mouse model of tauopathy|
O Ismail, IF Harrison, H Holmes, N Colgan, JA Wells, JM O'Callaghan, ...
Alzheimer's & Dementia 11 (7S_Part_7), P348-P348, 2015
|IC‐P‐211: AN IMAGING STRATEGY TO CHARACTERISE TAU PATHOLOGY IN VIVO IN A MODEL OF ALZHEIMER'S DISEASE USING MULTI‐PARAMETRIC MRI|
HE Holmes, O Ismail, J Wells, J O'Callaghan, N Powell, T Murray, ...
Alzheimer's & Dementia 10, P114-P115, 2014
|Neurite orientation dispersion and density imaging (NODDI) to investigate tau pathology in a TG4510 mouse model of Alzheimer’s|
N Colgan, B Siow, JMO Callaghan, JA Wells, HE Holmes, NM Powell, ...